BioPharmSignal logoBioPharmSignal

Biotech News

embecta Completes Acquisition of Owen Mumford Holdings Limited

Embecta (EMBC)EmbectaCompany update

PARSIPPANY, N.J., May 15, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global leader in diabetes care technology, today announced that it has completed its previously announced transaction to acquire Owen Mumford Holdings Limited (“Owen Mumford”), a privately held, UK-based

Related news

EMBCEmbecta2026-03-19 10:30 EST

embecta Announces Definitive Agreement to Acquire Owen Mumford Holdings Limited

EMBCEmbecta2026-08-07 10:30 EST

Embecta Corp. Reports Third Quarter Fiscal 2026 Financial Results

SENSSenseonics2026-05-01 13:10 EST

Senseonics Holdings, Inc. Schedules First Quarter 2026 Earnings Release and Conference Call for May 7, 2026 at 4:30 P.M. Eastern Time

View all latest news

Embecta

Global Diabetes Care Embecta is a global diabetes-care company built on a nearly century-long history in insulin delivery. Its products are used by people who self-administer injectable therapies and by healthcare systems supporting diabetes management. Injection-Device Portfolio The company's core portfolio includes pen needles and...

Recent company news

EMBCEmbecta2026-08-07 10:30 EST

Embecta Corp. Reports Third Quarter Fiscal 2026 Financial Results

EMBCEmbecta2026-08-07 10:00 EST

embecta Announces Quarterly Cash Dividend

EMBCEmbecta2026-07-23 21:00 EST

embecta to Report Fiscal Third Quarter Financial Results

EMBCEmbecta2026-06-16 10:30 EST

embecta appoints Nimish Muzumdar as SVP and President, North America

EMBCEmbecta2026-06-01 21:00 EST

embecta to Participate in Investor Events

Stock data

Close
3.50 USD
Market cap
207.05M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States